CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma
Clinical trial NCT04047303 · TERMINATED
Trial details
- NCT number
- NCT04047303
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-02
- Primary completion
- 2024-06-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.